New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Thursday, November 20, 2014 In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/new-findings-clarify-how-immunotherapy-works-and-why-in-some-people-it-doesnt/" align="left"]
[divider_top]

Genetic “Kill Switch” Could Make Cell Therapies Safer

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Thursday, September 18, 2014 Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/genetic-kill-switch-could-make-cell-therapies-safer/" align="left"]
[divider_top]

Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting

Add a Comment By Media Staff   |  Wednesday, June 4, 2014 Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/memorial-sloan-ketterings-expertise-in-cancer-immunotherapy-draws-media-focus-at-2014-asco-meeting/" align="left"]
[divider_top]

New Immunotherapy Approach for Breast Cancer Shows Promise

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, June 3, 2014 The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/new-immunotherapy-approach-for-breast-cancer-shows-promise/" align="left"]
[divider_top]

Memorial Sloan Kettering’s Jedd Wolchok Describes Stunning Success of Cancer Immunotherapy in Scientific American Feature

2 comments By Jim Stallard, MA, Writer/Editor   |  Friday, May 2, 2014 Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in Scientific American . read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/memorial-sloan-ketterings-jedd-wolchok-describes-stunning-success-of-cancer-immunotherapy-in-scientific-american-feature/" align="left"]
[divider_top]

Memorial Sloan Kettering’s Jedd Wolchok Describes Stunning Success of Cancer Immunotherapy in New York Times and Scientific American Features

22 comments By Jim Stallard, MA, Writer/Editor   |  Friday, May 2, 2014 Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American . read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/memorial-sloan-ketterings-jedd-wolchok-describes-stunning-success-of-cancer-immunotherapy-in-new-york-times-and-scientific-american-features/" align="left"]
[divider_top]

Memorial Sloan Kettering Featured Prominently at Major Cancer Research Meeting

Add a Comment By Media Staff   |  Thursday, April 10, 2014 Discoveries made at Memorial Sloan Kettering receive recognition at the 2014 Annual Meeting of the American Association for Cancer Research. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/memorial-sloan-kettering-featured-prominently-at-major-cancer-research-meeting/" align="left"]
[divider_top]